A pioneering treatment that can reverse a form of childhood vision loss by inserting DNA directly into the eye is on track for regulatory approval in the US, after a panel of scientists endorsed unanimously the “gene therapy” being developed by Spark Therapeutics.
一种将DNA直接植入眼睛以逆转某类儿童视力丧失的开创性疗法，有望得到美国监管机构的批准。此前，一个由科学家组成的顾问委员会对这种由Spark Therapeutics研发的“基因疗法”表示了一致的支持。
您已阅读15%（365字），剩余85%（2138字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。